Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Changes of tumor size and tumor contrast enhancement during radiotherapy for non-small-cell lung cancer may be suggestive of treatment response.

Okada H, Hontsu S, Miura S, Asakawa I, Tamamoto T, Katayama E, Iwasaki S, Kimura H, Kichikawa K, Hasegawa M.

J Radiat Res. 2012;53(2):326-32. Epub 2012 Feb 13.

2.

Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study.

Werner-Wasik M, Xiao Y, Pequignot E, Curran WJ, Hauck W.

Int J Radiat Oncol Biol Phys. 2001 Sep 1;51(1):56-61.

PMID:
11516851
3.

Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy.

Hwang SH, Yoo MR, Park CH, Jeon TJ, Kim SJ, Kim TH.

Eur Radiol. 2013 Jun;23(6):1573-81. doi: 10.1007/s00330-012-2755-0. Epub 2013 Jan 9.

PMID:
23300040
4.

Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC).

Edet-Sanson A, Dubray B, Doyeux K, Back A, Hapdey S, Modzelewski R, Bohn P, Gardin I, Vera P.

Radiother Oncol. 2012 Feb;102(2):251-7. doi: 10.1016/j.radonc.2011.07.023. Epub 2011 Aug 30.

PMID:
21885145
5.

Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography.

Ng QS, Goh V, Milner J, Padhani AR, Saunders MI, Hoskin PJ.

Int J Radiat Oncol Biol Phys. 2007 Feb 1;67(2):417-24.

PMID:
17236965
6.
7.

Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer.

Fox J, Ford E, Redmond K, Zhou J, Wong J, Song DY.

Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):341-8. doi: 10.1016/j.ijrobp.2008.07.063. Epub 2008 Nov 27.

PMID:
19038504
8.

Change in contrast enhancement of HCC on 1-month follow-up CT after local radiotherapy: an early predictor of final treatment response.

Kim EY, Choi D, Lim DH, Lee WJ, Yoo BC, Paik SW.

Eur J Radiol. 2009 Dec;72(3):440-6. doi: 10.1016/j.ejrad.2008.07.036. Epub 2008 Sep 25.

PMID:
18819767
9.

A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer.

Kong FM, Frey KA, Quint LE, Ten Haken RK, Hayman JA, Kessler M, Chetty IJ, Normolle D, Eisbruch A, Lawrence TS.

J Clin Oncol. 2007 Jul 20;25(21):3116-23.

PMID:
17634490
10.

Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: observations on tumor regression during treatment.

Kupelian PA, Ramsey C, Meeks SL, Willoughby TR, Forbes A, Wagner TH, Langen KM.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1024-8. Epub 2005 Jul 11.

PMID:
16005575
11.

Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?

Gillham C, Zips D, Pönisch F, Evers C, Enghardt W, Abolmaali N, Zöphel K, Appold S, Hölscher T, Steinbach J, Kotzerke J, Herrmann T, Baumann M.

Radiother Oncol. 2008 Sep;88(3):335-41. doi: 10.1016/j.radonc.2008.05.004. Epub 2008 May 29.

PMID:
18514339
12.

Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.

Everitt S, Hicks RJ, Ball D, Kron T, Schneider-Kolsky M, Walter T, Binns D, Mac Manus M.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1098-104. doi: 10.1016/j.ijrobp.2008.12.039. Epub 2009 Apr 20.

PMID:
19386444
14.

Early evaluation of targeted therapy effectiveness in non-small cell lung cancer by dynamic contrast-enhanced CT.

Qiao PG, Zhang HT, Zhou J, Li M, Ma JL, Tian N, Xing XD, Li GJ.

Clin Transl Oncol. 2016 Jan;18(1):47-57. doi: 10.1007/s12094-015-1335-6. Epub 2015 Aug 5.

PMID:
26243393
15.

Gross tumour volume variations in primary non-small-cell lung cancer during the course of treatment with stereotactic body radiation therapy.

Gunter T, Ali I, Matthiesen C, Machiorlatti M, Thompson D, Algan O.

J Med Imaging Radiat Oncol. 2014;58(3):384-91. doi: 10.1111/1754-9485.12168. Epub 2014 Mar 5.

PMID:
24592817
16.

Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers.

Onimaru R, Shirato H, Shimizu S, Kitamura K, Xu B, Fukumoto S, Chang TC, Fujita K, Oita M, Miyasaka K, Nishimura M, Dosaka-Akita H.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):126-35.

PMID:
12694831
17.

Evaluating FDG uptake changes between pre and post therapy respiratory gated PET scans.

Aristophanous M, Yong Y, Yap JT, Killoran JH, Allen AM, Berbeco RI, Chen AB.

Radiother Oncol. 2012 Mar;102(3):377-82. doi: 10.1016/j.radonc.2011.12.015. Epub 2012 Jan 20.

PMID:
22265731
18.

Changes in global function and regional ventilation and perfusion on SPECT during the course of radiotherapy in patients with non-small-cell lung cancer.

Yuan ST, Frey KA, Gross MD, Hayman JA, Arenberg D, Cai XW, Ramnath N, Hassan K, Moran J, Eisbruch A, Ten Haken RK, Kong FM.

Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):e631-8. doi: 10.1016/j.ijrobp.2011.07.044. Epub 2011 Dec 22.

19.

Quantitative helical dynamic contrast enhanced computed tomography assessment of the spatial variation in whole tumour blood volume with radiotherapy in lung cancer.

Ng QS, Goh V, Milner J, Sundin J, Wellsted D, Saunders MI, Hoskin PJ.

Lung Cancer. 2010 Jul;69(1):71-6. doi: 10.1016/j.lungcan.2009.09.002. Epub 2009 Sep 24.

PMID:
19781806

Supplemental Content

Support Center